Kantonsspital St.Gallen
login

publications

Stefanie Müller

title  
 
Heckmann J, Todorova M, Müller S, Broser P J, Sturm V. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis. Klin Monbl Augenheilkd. 2020;.
   
Müller S, Vehoff J. Aktuelle Therapien der Multiplen Sklerose. der informierte @rzt 2019; Vol. 9:26-27.
   
Uffer D, Müller S, Vehoff J. Multiple Sklerose: Neues zur monoklonalen Antikörpertherapie. InFo NEUROLOGIE & PSYCHIATRIE 2018; 1:15-18.
   
Kamm C P, Muehl S, Mircsof D, Müller S, Czaplinski A, Achtnichts L, Stellmes P, Di Virgilio G. Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey. Front Neurol 2018; 9:821.
   
Pardini M, Botzkowski D, Müller S, Vehoff J, Kuhle J, Ruberte E, Würfel J, Gass A, Valmaggia C, Tettenborn B, Putzki N, Yaldizli . The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. Eur J Neurol 2016;.
   
Disanto G, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E W, Sprenger T, Stippich C, Derfuss T, Louvion J F, Kamm C P, Mattle H P, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P H, Yaldizli , Gobbi C, Kappos L, Kuhle J, . The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS ONE 2016; 11:e0152347.
   
Müller S. Behandlung eines Multiple-Sklerose-Schubs - Orale versus intravenöse Steroide. InFo NEUROLOGIE & PSYCHIATRIE 2015; Vol. 14, Nr. 1 2015; Vol. 14:5-5.
   
Engeler D S, Meyer D, Abt D, Müller S, Schmid H P. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol 2015; 15:105.
   
Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M. Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies. Eur Neurol 2013; 70:35-41.
   
Vehoff J, Müller S, Tettenborn B. Multiple Sklerose: Neue Diagnosekriterien und neue Therapiemöglichkeiten. InFo Neurologie & Psychiatrie 2011; Vol.9:.
   
Hundsberger T, Müller S, Sommacal A, Fretz C, Tettenborn B. Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?. Schweizer Archiv für Neurologie und Psychiatrie 2010; 161:262-265.
   
Müller S, Schött D, Altland K, Tettenborn B. Hereditary transthyretin amyloidosis: a case report of a newly described TTR variant Ile 107 Met. Schweiz Arch Neurol Psych 2004; 155:91-92.
   
Vehoff J, Hägele-Link S, Humm A, Müller S, Sauter R, Tettenborn B, & Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial. In Session PRS2102 Autonomic nervous system 2 (pp. 2013): EAN.
   
Muehl S, Czaplinski A, Stelmess P, Kamm C P , Müller S, & Muehl S (2016). Role of family planning in women of child-bearing age with multiple sclerosis (MS) in Switzerland: Results of the Women. In (pp. 1): keiner.
   
Pardini M, Botzkowski D, Müller S, Vehoff J, Kuhle J, Gass A, Würfel J, Valmaggia C, Tettenborn B, Putzki N, & Yaldizli (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study. In P1004 (pp. 1): kein.
   
prochnicki a, Zieglgänsberger D, Vehoff J, Müller S, Tettenborn B, & Hundsberger T (2015). Glioblastoma multiforme: Chameleon of neurology A case report. In (pp. 1).
   
Disanto G, Benkert P, Lohrscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, Stippich C, Derfuss T, Louvion J F, Kamm C, Mattle H, Lotter C, du Pasquier R, Schluepp M, Pot C, Lalive P, Kappos L, & Kuhle J (2015). The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs. In P775 (pp. 1): keiner.
   
Döhler N, Müller S, Vehoff J, Galovic M, & Tettenborn B (2014). Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab. In P327 (pp. 1): keiner.
   
yildiz m, Müller S, Vehoff J, & Tettenborn B (2011). Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up. In P03.225 (pp. 1): keiner.
   
Müller S, Bönig L, von Manitius S, Weder B, & Tettenborn B (2009). Abnormal sleep/wake-patterns in. Presented at 173. Tagung der Schweizerischen Neurologischen Gesellschaft in Luzern.
   
Vehoff J, & Müller S (2009). Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy. Presented at Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft SNG (182. Tagung), Interlaken.
   
Müller S, Endress E, Schött D, & Hägele-Link S (2006). Anti-Hu syndrome preceding a carcinoma of the vocal cords. Presented at 177. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken).
   
Müller S, Endress E, Schött D, Hägele-Link S, & Tettenborn B (2006). Anti-Hu syndrome preceding a carcinoma of the vocal cords. Presented at 177. Tagung Schweiz. Neurologischen Gesellschaft, Interlaken.
   
Müller S, Tettenborn B, & Bönig L (2005). Wound botulism in an injection drug user. Presented at 176. Tagung der Schweizerischen Neurologischen Gesellschaft (St. Gallen).
   
Müller S, Tettenborn B, Schött D, & Altland K (2004). Hereditary transthyretin amyloidosis:a case report of a newly described TTR variant Ile 107Met. Presented at 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken), 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken).
   
Müller S, Schött D, Altland K, & Tettenborn B (2003). Hereditary transthyretin amyloidosis: a case report of a newly described TTR variant Ile 107 Met. Presented at Joint Meeting of the Swiss Society for Neurology (SNG) and the Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SGSSC), Zürich.
   
 
page 1 of 1